Cargando…

In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)

Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafferty, Eamon P., Wylie, Alastair R., Elliott, Chris T., Chevallier, Olivier P., Grieve, David J., Green, Brian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Österreichische Apotheker-Verlagsgesellschaft 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163370/
https://www.ncbi.nlm.nih.gov/pubmed/21886907
http://dx.doi.org/10.3797/scipharm.1104-16
_version_ 1782210939759624192
author Rafferty, Eamon P.
Wylie, Alastair R.
Elliott, Chris T.
Chevallier, Olivier P.
Grieve, David J.
Green, Brian D.
author_facet Rafferty, Eamon P.
Wylie, Alastair R.
Elliott, Chris T.
Chevallier, Olivier P.
Grieve, David J.
Green, Brian D.
author_sort Rafferty, Eamon P.
collection PubMed
description Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS), beta casein (BCAS) and chlorogenic acid (CGA) were assessed in STC-1 cells and C57BL/6 mice. All compounds except ACAS significantly increased acute in vitro GLP-1 secretion (66–386%; P<0.05–0.001). Oral gavage of OLE and GLN modestly increased plasma GLP-1 concentrations (48% and 41%, respectively), but did not lower glycaemic excursions. OLE and GLN are potent stimulators of GLP-1 secretion both in vitro and in vivo and chronic studies should assess their suitability as nutritional therapies for type 2 diabetes.
format Online
Article
Text
id pubmed-3163370
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Österreichische Apotheker-Verlagsgesellschaft
record_format MEDLINE/PubMed
spelling pubmed-31633702011-09-01 In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) Rafferty, Eamon P. Wylie, Alastair R. Elliott, Chris T. Chevallier, Olivier P. Grieve, David J. Green, Brian D. Sci Pharm Short Communication Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS), beta casein (BCAS) and chlorogenic acid (CGA) were assessed in STC-1 cells and C57BL/6 mice. All compounds except ACAS significantly increased acute in vitro GLP-1 secretion (66–386%; P<0.05–0.001). Oral gavage of OLE and GLN modestly increased plasma GLP-1 concentrations (48% and 41%, respectively), but did not lower glycaemic excursions. OLE and GLN are potent stimulators of GLP-1 secretion both in vitro and in vivo and chronic studies should assess their suitability as nutritional therapies for type 2 diabetes. Österreichische Apotheker-Verlagsgesellschaft 2011 2011-06-09 /pmc/articles/PMC3163370/ /pubmed/21886907 http://dx.doi.org/10.3797/scipharm.1104-16 Text en © Rafferty et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Rafferty, Eamon P.
Wylie, Alastair R.
Elliott, Chris T.
Chevallier, Olivier P.
Grieve, David J.
Green, Brian D.
In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
title In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
title_full In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
title_fullStr In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
title_full_unstemmed In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
title_short In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
title_sort in vitro and in vivo effects of natural putative secretagogues of glucagon-like peptide-1 (glp-1)
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163370/
https://www.ncbi.nlm.nih.gov/pubmed/21886907
http://dx.doi.org/10.3797/scipharm.1104-16
work_keys_str_mv AT raffertyeamonp invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1
AT wyliealastairr invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1
AT elliottchrist invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1
AT chevallierolivierp invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1
AT grievedavidj invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1
AT greenbriand invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1